Woodside Energy Group Ltd
WDS
Origin Energy Ltd
ORG
National Australia Bank Ltd
NAB
Telstra Group Ltd
TLS
ANZ Group Holdings Ltd
ANZ
澳洲市场个股详情
OPTOB Opthea Ltd
- 0.350
- +0.070+25.00%
延时20分钟行情休市中 12/24 13:38 (悉尼)
4.31亿总市值0.00市盈率(静)
0.350最高价0.300最低价3193股成交量0.300今开0.280昨收1101.00成交额0.42052周最高0.00%换手率12.31亿总股本0.10052周最低--每股收益TTM2.71亿流通值0.420历史最高0.00市盈率(静)7.73亿流通股0.100历史最低--每股收益(静)17.86%振幅--股息TTM0.00市净率1股每手--股息率TTM
关于Opthea Ltd公司
Opthea Ltd 经营的一个行业是医疗技术和医疗保健。它专注于开发眼病的生物疗法。该公司正在开发一种新型生物疗法 OPT-302，用于治疗眼病。其产品基于涵盖血管内皮生长因子 C 和 D 以及 R3 靶点的知识产权组合。Opthea 的开发活动基于涵盖关键靶点血管内皮生长因子 VEGF-C、VEGF-D 和 VEGF 受体-3 的知识产权组合，用于治疗与血液和淋巴管生长以及血管渗漏相关的疾病。该公司在澳大利亚和美国开展业务。
公司介绍
公司代码OPTOB
公司名称Opthea Ltd
成立日期1984
所属市场ASX
员工数量34
年结日06-30
公司地址650 Chapel Street Level 4, Suite 0403
城市South Yarra
国家澳大利亚
邮编3141
电话+61 398260399
股份登记处COMPUTERSHARE INVESTOR SERVICES PTY LIMITED
Yarra Falls, 452 Johnston Street, ABBOTSFORD, VIC, AUSTRALIA, 3067
03 9415 4000
董事高管
- 姓名
- 职务
- 年薪
- Dr. Frederic Guerard, Pharm.D.
- Chief Executive Officer
- 131.81万
- Peter F. Lang
- Chief Financial Officer
- 116.13万
- Dr. Megan Baldwin
- Chief Innovation Officer and Executive Director
- 135.97万
- Judith J. Robertson
- Chief Commercial Officer
- 71.51万
- Dr. John Han
- Vice President, Medical Affairs
- --
- Julie Clark
- Senior Vice President, Clinical Development
- --
- Bruno Gagnon
- Senior Vice President, Global Clinical Operations
- --
- Kevin Bitter
- Vice President, Strategy & Corporate Development
- --
- Fang Li, PhD
- Senior Vice President, Regulatory
- --
- Karen Adams
- Vice President, Finance and Company Secretary
- 46.62万
- Mark O Neill
- Vice President, Chemistry, Manufacturing and Controls
- --
- Jeremy M. Levin, D.Phil.,M.B.
- Chairman of the Board
- 30.94万
- Dr. Julia A. Haller, M.D.
- Director
- 17.03万
- Anshul Thakral
- Director
- 10.37万
- Quinton Oswald
- Independent Director
- 13.58万
- Lawrence B. Gozlan
- Independent Director
- 79.05万
- Sujal Shah
- Independent Director
- 1.67万
- Susan Orr
- Independent Director
- 13.03万